Can Lead Cause Cancer? The Health Risks of Exposure

Lead is classified as reasonably anticipated to be a human carcinogen by the U.S. National Toxicology Program, and the International Agency for Research on Cancer (IARC) lists inorganic lead compounds as probably carcinogenic to humans (Group 2A). The evidence linking lead to cancer is strongest for lung and stomach cancers, with growing but less consistent findings for brain, kidney, and bladder cancers. Beyond cancer, lead damages nearly every organ system, from the heart and kidneys to the developing brain, which makes it one of the most broadly toxic substances people still routinely encounter.

How Regulators Classify Lead’s Cancer Risk

The National Toxicology Program’s 15th Report on Carcinogens, released in December 2021, lists 256 substances that are known or reasonably anticipated to cause cancer in humans. Lead and lead compounds are on that list in the “reasonably anticipated” category, a designation based on sufficient evidence from animal studies and supporting evidence from human epidemiology.¹ IARC’s Group 2A classification for inorganic lead compounds carries a similar meaning: there is limited but credible evidence in humans and strong evidence in animals. Neither agency calls lead a “known” human carcinogen, because the epidemiological picture in people, while troubling, hasn’t reached the level of certainty that substances like asbestos or benzene have. That distinction matters less than it sounds, though. “Reasonably anticipated” still triggers workplace protections, exposure limits, and monitoring requirements.

Which Cancers Are Linked to Lead Exposure

The epidemiological evidence is not uniform across cancer types. Some sites show consistent associations across multiple study designs, while others have mixed or null results. A 2024 systematic review that pulled together decades of research found the most consistent evidence for cancers of the gastrointestinal tract, including the esophagus, stomach, colon-rectum, and pancreas, as well as bladder and urinary tract cancers.²

Stomach Cancer

Stomach cancer has been one of the more reliably observed associations. A large cohort study following men and women in Shanghai found a suggestive elevated risk in men with high lead exposure, with about a 60% increase compared to unexposed men, though the same pattern did not appear in women.³ A separate case-control study found a threefold increase in stomach cancer risk among workers exposed to organic lead compounds.⁴ These are the kinds of numbers that make researchers take the association seriously even when individual studies don’t always agree on magnitude.

Lung Cancer

Lung cancer is another site with substantial evidence. A large cohort study of lead-exposed workers found strong positive associations between blood lead levels and both lung cancer mortality and lung cancer incidence, with a marked upward trend at higher lead levels.⁵ A 2025 Korean study found that workers with blood lead levels at or above roughly 5 µg/dL had about three times the expected lung cancer incidence compared to workers with the lowest levels, and the relationship showed a clear dose-response pattern.⁶ An older Swedish study similarly found about a 1.8-fold increase in lung cancer incidence among workers whose blood lead had ever reached elevated levels.⁷

Brain Tumors

A meta-analysis pooling data from multiple studies found no significant overall link between lead exposure and brain tumors when benign and malignant types were lumped together. But when the analysis was restricted to malignant brain tumors specifically, a small but statistically significant increase in risk emerged, with a pooled odds ratio of about 1.13.⁸ That’s a modest increase, and it sits at the edge of what epidemiologists consider meaningful, so the brain tumor connection remains an open question rather than a settled finding.

Kidney Cancer

The kidney cancer story is surprisingly mixed given that lead is known to damage the kidneys. A well-designed case-control study found no association between cumulative occupational lead exposure and kidney cancer risk.⁹ However, a separate study comparing blood metal concentrations in people with renal cell carcinoma to healthy controls found significantly higher lead levels in cancer patients.¹⁰ That kind of finding doesn’t prove causation, since higher lead levels might be a consequence of impaired kidney function rather than the cause of the cancer. This is one of those areas where the evidence genuinely points in different directions.

How Lead Promotes Cancer at the Cellular Level

Lead is unusual among carcinogens because it doesn’t directly mutate DNA the way, say, ultraviolet radiation or tobacco smoke chemicals do. Instead, it works through several indirect routes that collectively push cells toward becoming cancerous.

The most well-documented mechanism involves oxidative stress. Lead generates reactive oxygen species in cells, which in turn cause breaks in DNA strands. Studies of workers with occupational lead exposure have found significantly more DNA damage in their white blood cells compared to unexposed people, and the damage increases in a dose-dependent way. Workers with the highest exposure had about 20% more DNA in the “tail” of a comet assay (a standard measure of DNA breakage) compared to controls.¹¹ Another study confirmed that these elevated DNA breaks correlate with increased production of reactive oxygen species and decreased levels of glutathione, the body’s main antioxidant defense molecule.¹²

Making matters worse, lead also interferes with the cell’s ability to repair that DNA damage. Research has shown that lead inhibits DNA repair systems, and the combination of increased damage and decreased repair capacity is a recipe for the kind of accumulated genetic errors that can initiate cancer.¹³ When workers are co-exposed to lead alongside other metals like cadmium or cobalt, the repair inhibition becomes even more pronounced, because the reduced repair capacity amplifies the damage caused by all of them.¹⁴

A third mechanism involves epigenetic changes. Lead exposure in cell cultures has been shown to alter DNA methylation patterns, essentially flipping molecular switches that control whether certain genes are turned on or off. In one study, lead treatment changed the methylation and expression of growth-related genes like IGF2 and PEG1/MEST, with some of the most dramatic shifts occurring at exposure levels as low as the equivalent of 20 µg/dL, a concentration not far above what some exposed workers carry.¹⁵

Lead also physically displaces zinc in zinc finger proteins, which are critical molecular structures that many transcription factors use to bind DNA and regulate gene activity. Researchers have shown that lead interferes with the DNA-binding properties of several zinc finger transcription factors, effectively disrupting normal gene regulation.¹⁶ The inhibition follows a specific pattern: lead binds to the zinc finger structure itself, and when the protein is already bound to DNA or RNA, lead can’t displace the zinc, confirming that the zinc binding site is the target.¹⁷ This same displacement mechanism also contributes to neurological damage and may play a role in neurodegenerative diseases.¹⁸

When Lead Exposure Combines with Other Hazards

Workers exposed to lead rarely encounter it in isolation. Mining, smelting, battery manufacturing, and construction sites often involve simultaneous exposure to arsenic, cadmium, diesel exhaust, and other known or suspected carcinogens. This matters because research suggests the cancer risk from lead combined with other metals is greater than what you’d expect from each one individually. One study found that lead exposure alone was associated with odds ratios for lung cancer hovering around 1.0, meaning no meaningful increase. But when lead exposure was combined with arsenic or cadmium, the odds ratios jumped above 2.0, suggesting a synergistic effect.¹⁹ The Swedish lung cancer study mentioned earlier similarly found that the strongest increase in lung cancer risk appeared among workers exposed to both lead and engine exhaust.⁷

This complicates the question of whether lead alone is a strong enough carcinogen to worry about at typical population-level exposures. Much of the clearest cancer evidence comes from occupational settings where lead is present alongside other hazards, making it difficult to isolate lead’s independent contribution. That said, the biological mechanisms described above don’t require a co-exposure to operate. Lead-only cell cultures still show DNA damage, repair inhibition, and epigenetic disruption.

The Non-Cancer Health Risks That Often Matter More

Cancer gets the headlines, but for most people exposed to lead, the cardiovascular, neurological, and kidney effects are more immediate threats. A systematic review of lead and cardiovascular disease found positive associations between lead exposure and coronary heart disease, stroke, and peripheral arterial disease. In prospective studies, relative risks for coronary heart disease ranged up to about 1.9 at blood lead levels as low as a few micrograms per deciliter.²⁰ A Swedish population-based study added further evidence, finding that lead exposure was associated with coronary artery calcification in men, a direct marker of atherosclerosis.²¹

Kidney damage follows a similar pattern. A 16-year follow-up study found that people with higher blood lead levels at the start of the study experienced a greater decline in kidney function over time, with those in the highest group facing about a 49% higher risk of significant kidney function loss.²² And childhood lead exposure has been linked to lower cognitive functioning decades later in old age, a reminder that the neurological harm from lead has a very long tail.²³

Lead also disrupts the endocrine system. It accumulates in the ovaries and testes and can blunt the hormonal signals from the pituitary gland. The result includes reduced fertility, delayed pubertal development in children, and impaired sperm production and testosterone regulation in men.²⁴

Lead Stored in Bone Can Re-Enter the Bloodstream

One of the more unsettling facts about lead is that your body treats it somewhat like calcium and deposits it in bone, where it can sit for decades. This is not a safe storage arrangement. During pregnancy, when the body pulls calcium from bones to build the fetal skeleton, stored lead comes along for the ride. Research tracking pregnant women using isotopic measurements found that roughly a third of the lead in their blood during pregnancy came from their own bones rather than from any current environmental exposure.²⁵ The skeletal contribution was even higher during breastfeeding. A separate study confirmed these findings, reporting a mean increase in skeletal lead contribution of about 31% during pregnancy.²⁶

Menopause creates a similar problem. As bone density naturally declines, stored lead re-enters circulation. An analysis of national survey data found a highly significant increase in blood lead levels in postmenopausal women compared to premenopausal women, confirming that bone is not a permanent vault but more like a slow-release reservoir.²⁷ This means someone whose childhood lead exposure happened 40 or 50 years ago can face a resurgence of lead in their blood at a time when their body is already dealing with age-related health challenges.

Who Is Most Exposed and Why

Lead exposure in the general population has plummeted since leaded gasoline was phased out. That single policy change enabled many countries to bring average blood lead levels down to about 1 µg/dL or lower, saving lives, increasing children’s intelligence, and generating enormous economic benefits.²⁸ But the decline hasn’t been equal across communities.

Analysis of nearly two decades of national survey data shows that non-Hispanic Black children and children from low-income families continue to have higher blood lead levels than their peers, even after accounting for other factors.²⁹ The reasons are structural. Black families are more likely to live in older housing with lead paint and lead plumbing, and their neighborhoods tend to have higher soil lead concentrations even after adjusting for socioeconomic status.³⁰ The Flint, Michigan water crisis brought renewed attention to drinking water as a route of exposure, and subsequent research confirmed that area-level measures of race, poverty, and older housing all predict children’s blood lead levels independently.³¹

There is no known safe blood lead level. The CDC has made this explicit, noting that even small amounts of lead can harm a child’s developing brain.³² The current blood lead reference value for children is 3.5 µg/dL, but that is not a safety threshold. It is a statistical benchmark representing roughly the 97.5th percentile of blood lead levels in U.S. children, intended to identify children with unusually high exposure for follow-up, not to define a level below which lead is harmless.

What Chelation Therapy Can and Cannot Do

When blood lead levels climb high enough, chelation therapy becomes an option. Chelating agents are drugs that bind to lead in the bloodstream and help the body excrete it through urine. The three agents primarily used are dimercaprol, edetate calcium disodium, and succimer. Chelation is generally not recommended for adults with blood lead below 45 µg/dL because of the risk of side effects and concerns about the drugs temporarily mobilizing lead from bone into the bloodstream, potentially worsening short-term exposure to soft tissues.³³

Studies in animal models have clarified how the different chelating agents work. Succimer appears particularly effective at reducing bone lead stores, while edetate calcium disodium is better at lowering brain lead levels. With extended treatment, both agents reduce lead levels across the kidneys, bones, and brain, but succimer produces greater reductions in bone lead.³⁴ In people with chronic lead poisoning, chelation has been shown to reduce liver stiffness, lower inflammatory markers, and boost antioxidant levels, suggesting the treatment reverses at least some of the ongoing tissue damage.³⁵

Chelation, however, cannot undo all the harm. It does not reverse cognitive damage from childhood exposure, and there is no evidence it reduces cancer risk in someone who has already accumulated years of lead exposure. Its primary value is stopping ongoing high-level poisoning. For most people with low-to-moderate exposure, the better strategy is prevention: identifying and eliminating the sources of lead in your environment rather than trying to remove it from your body after the fact.

Lead’s Effects on Fertility and Hormones

Beyond the well-known risks to the brain and heart, lead has a less-publicized ability to disrupt reproductive health. It accumulates in the ovaries’ granulosa cells and in testicular tissue, where it can interfere with the hormonal signals that drive fertility. In men, the pattern tends to start with direct damage to testicular function and, with longer exposure, progresses to disruption of the hypothalamic-pituitary axis, the hormonal command center that regulates testosterone and sperm production.²⁴ In women, lead exposure has been associated with delayed growth and pubertal development and reduced fertility. Experimental research in fish models has confirmed that lead impairs egg and sperm development, disrupts estrogen receptor signaling, and alters reproductive biomarkers even at relatively low concentrations.³⁶ The combination of bone-stored lead re-entering the bloodstream during pregnancy and the direct effects on reproductive hormones creates a particularly concerning window for women of childbearing age who grew up with higher lead exposure decades ago.